AzTrials
AzTrials

Corticospinal PlasticityNCT03334526

Study of the Reaction of the Brain to Various Stimulations

A study testing physical training, mental training and electrical stimulation in people with Corticospinal Plasticity and Neuromuscular Plasticity, run by Centre Hospitalier Universitaire Dijon at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Physical activity is considered a therapeutic strategy in its own right in a vast majority of disabling chronic disorders. It leads to an increase in physical and probably cognitive capacity, thanks to its effects on both metabolism (muscle hypertrophy, improvement in oxidative metabolism) and the nervous system… Read more about this study

Who is it for?
Ages 18 to 60 yearsHealthy volunteers can take part
What is being tested?
physical training, mental training and electrical stimulation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
174 participants
Where
1 siteFrance
Study dates
9 Nov 2017to 24 Jun 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • persons who have provided written consent
  • healthy subjects
  • national health insurance cover
  • age 18 to 60 years

Who cannot join

  • personal or family history of epilepsy
  • pacemakers or other apparatus likely to interfere with the magnetic field
  • history of psychiatric disease
  • Persons under guardianship or wards of court
  • Pregnant or breast-feeding women
  • problem perceived during the neurological examination which could bias the results of the study

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU Dijon Bourgogne

    Dijon, 21079

Other trials in France

About this study

Official title: Corticospinal and Neuromuscular Plasticity Induced by Real and Imaginary Contractions.

Physical activity is considered a therapeutic strategy in its own right in a vast majority of disabling chronic disorders. It leads to an increase in physical and probably cognitive capacity, thanks to its effects on both metabolism (muscle hypertrophy, improvement in oxidative metabolism) and the nervous system (neuroplasticity). Nonetheless, even though there is a consensus on the positive effects of physical exercise (PE) on cerebral plasticity, the physiological mechanisms by which PE affects neuroplasticity, in particular depending on the mode of muscle contraction, are still hypothetical. Moreover, several recent studies have shown that mental learning (ML) by motor imagery improves motor performance, thus making it of interest in a context of rehabilitation, in particular in situations where PE is transient of definitively impossible. Yet, the mechanisms and brain structures involved in motor learning by ML have not been established so far. Finally, on the basis of clinical observations concerning the key role of sensory input in motor function, the hypothesis that increased demand on this input by electrical stimulation (ES) as a means to improve motor function has been proposed. However, the mechanisms by which this type of stimulation could induce neuroplasticity is still to be elucidated.

Being tested
physical training, mental training, electrical stimulation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • physical trainingOther

    workout on treadmill requiring the muscles of the lower limbs mostly in concentric (ascent) or eccentric (downhill)

  • mental trainingOther

    The task to imagine for the training group will be an abduction of the thumb

  • electrical stimulationOther

    electrical stimulation of the muscles

Study groups in NCT03334526
Study groupRoleWhat they receive
healthy volunteersExperimentalNot described
Receives: Other: physical training; Other: mental training; Other: electrical stimulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. level of corticospinal excitability

    Measured: through study completion, an average of 4 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Nov 2017
  2. Study start9 Nov 2017
  3. Primary completion24 Jun 2022
  4. Study completion24 Jun 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Model description
this study is interventional because of it acts on the physical and respiratory capacities of patients
Masking
None (open label)
Enrolment
174 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03334526
Sponsor's protocol ID
GREMEAUX 2017
Status last verified
Feb 2023
First submitted
13 Oct 2017
Last updated
16 Feb 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Dupont W, Papaxanthis C, Lurquin L, Lebon F, Madden-Lombardi C. Negated actions are simulated within the primary motor cortex. Neuroscience. 2025 Jan 26;565:468-478. doi: 10.1016/j.neuroscience.2024.12.018. Epub 2024 Dec 12.

    PubMed 39674536
  • Dupont W, Papaxanthis C, Lebon F, Madden-Lombardi C. Mental Simulations and Action Language Are Impaired in Individuals with Aphantasia. J Cogn Neurosci. 2024 Feb 1;36(2):261-271. doi: 10.1162/jocn_a_02084.

    PubMed 37944123

Questions about this trial

What is this clinical trial studying?

A study testing physical training, mental training and electrical stimulation in people with Corticospinal Plasticity and Neuromuscular Plasticity, run by Centre Hospitalier Universitaire Dijon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

level of corticospinal excitability (time frame: through study completion, an average of 4 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03334526, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Feb 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in